All Pharma News
4D pharma plc (“4D pharma”) Receives Notice of Delisting From Nasdaq

4D pharma plc (“4D pharma”) Receives Notice of Delisting From Nasdaq
BUSINESSWIRE
28 Jun 2022
Share Share
4D pharma Presents Trial on Study of MRx0518 in Combination with BAVENCIO

4D pharma Presents Trial on Study of MRx0518 in Combination with BAVENCIO
BUSINESSWIRE
26 May 2022
Share Share
4D pharma to Present at the H.C. Wainwright Global Investment Conference

4D pharma to Present at the H.C. Wainwright Global Investment Conference
BUSINESSWIRE
19 May 2022
Share Share
4D pharma Presents Late Breaking Abstract from Phase I/II Trial of MRx-4DP0004

4D pharma Presents Late Breaking Abstract from Phase I/II Trial of MRx-4DP0004
BUSINESSWIRE
17 May 2022
Share Share
4D pharma Reports Full Year 2021 Financial Results

4D pharma Reports Full Year 2021 Financial Results
BUSINESSWIRE
31 Mar 2022
Share Share
Despite 0% response rate, 4D hits primary goal in cancer trial

Despite 0% response rate, 4D hits primary goal in cancer trial
N.P. Taylor FIERCEBIOTECH
24 Mar 2022
Share Share
Parkinson’s disease: Can an early phase live biotherapeutic make waves?

Parkinson’s disease: Can an early phase live biotherapeutic make waves?
Reynald Castaneda CLINICALTRIALSARENA
03 Mar 2022
Share Share
4D pharma to Participate at the Chardan Medicines Summit

4D pharma to Participate at the Chardan Medicines Summit
BUSINESSWIRE
23 Feb 2022
Share Share
FDA Clears 4D pharma`s IND for Live Biotherapeutics MRx0005 and MRx0029

FDA Clears 4D pharma`s IND for Live Biotherapeutics MRx0005 and MRx0029
BUSINESSWIRE
22 Feb 2022
Share Share
4D pharma receives US regulatory green light for phase I trial in Parkinson`s

4D pharma receives US regulatory green light for phase I trial in Parkinson`s
PRESS RELEASE
22 Feb 2022
Share Share